ARCHIVES

Clinical Trials: ECOG Says Results In Metastatic disease equivalent, Unlikely To change Over Time

This article is from The Cancer Letter archive.

Vol. 25 No. 15 | April 16, 1999

Download PDF Visit The Full Archive

Related Articles

FDA Committee Oks AMSA for Group C List, Tables THC Request, Deadlocks On Estramustine NDA

July 3, 1981

O’Leary Leads RPCI’s OR;

February 8, 2002

Seattle Panel Meeting Generate More Support For Increased Outreach Funding, Consortium Approached

November 2, 1984

In Brief: Cancer Control Month: Reagan Advises Americans To Stop Tobacco Use; Eat More Fiber, Less Fat

April 18, 1986

Drug Approvals: FDA Grants Accelerated Approval to Imbruvica

November 15, 2013

ODAC Reviews Post-Marketing Studies for Eight Indications

February 21, 2003